Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bluebird Bio
Bluebird Bio
Celgene, bluebird revise deal to co-develop CAR-T therapy
Biopharma Dive
Thu, 03/29/18 - 11:33 am
Celgene
Bluebird Bio
drug development
CAR-T
bb2121
Multiple Myeloma
bluebird bio Updates Plans for the Year Ahead
Motley Fool
Fri, 02/23/18 - 09:29 am
Bluebird Bio
earnings
How Celgene Hopes to Cash In on CAR-T
Yahoo/Motley Fool
Sat, 02/17/18 - 10:41 am
Celgene
CAR-T
JCAR017
bb2121
Bluebird Bio
As CAR-Ts go from candidates to brands, what's the marketing strategy?
Medical Marketing and Media
Tue, 02/13/18 - 09:01 am
CAR-T
drug marketing
JCAR017
Juno Therapeutics
Celgene
bb2121
Bluebird Bio
apalutamide
Janssen
2 Biotech Acquisition Candidates That Could Be Next in M&A Crosshairs
TheStreet.com
Mon, 01/29/18 - 09:29 am
biotech
M&A
Bluebird Bio
Amicus Therapeutics
3 Small Biotechs That Big Drugmakers Are Probably Drooling Over
Motley Fool
Mon, 01/29/18 - 09:17 am
biotech
Bluebird Bio
Madrigal Pharmaceuticals
SAGE Therapeutics
Bluebird Bio Shouldn’t Be Blue About Celgene’s Juno Deal
Washington Post, DC
Tue, 01/23/18 - 08:43 am
Bluebird Bio
Celgene
Juno Therapeutics
M&A
CAR-T
5 Biotech Stocks That Could Be Bought Out in 2018
Yahoo/Motley Fool
Sun, 01/14/18 - 09:38 am
biotech stocks
Portola Pharmaceuticals
Tesaro
Bluebird Bio
Esperion Therapeutics
GlycoMimetics
JPM18: bluebird set to file 3 drugs for approval by 2019
Biopharma Dive
Wed, 01/10/18 - 10:21 am
Bluebird Bio
JPMHC 2018
Lenti-D
gene therapy
LentiGlobin
bb2121
Celgene Shareholders Excited by CAR-T News
Motley Fool
Tue, 12/19/17 - 08:10 pm
Celgene
CAR-T
Bluebird Bio
bb2121
[video]ASH 2017 Recap: These Were the Big Winners and Losers
Motley Fool
Sat, 12/16/17 - 08:39 am
ASH2017
Bluebird Bio
Juno Therapeutics
Spark Therapeutics
Biomarin
JNJ
Celgene
5 Biotech Buyout Candidates for 2018
Yahoo/Motley Fool
Wed, 12/13/17 - 09:36 am
biotech
M&A
Biogen
Biomarin
Bluebird Bio
Geron
SAGE Therapeutics
bluebird bio Stock Soars on Unprecedented Blood Cancer Study Results
Motley Fool
Mon, 12/11/17 - 10:02 am
Bluebird Bio
bb2121
CAR-T
Celgene
Multiple Myeloma
ASH17
A Virus Shortage? BlueBird Bio Buys A Factory To Make Its Own
Forbes
Wed, 11/29/17 - 10:01 am
gene therapy
drug manufacturing
Bluebird Bio
9 Notable Biotechs Presenting At This Year's ASH Meeting
Yahoo
Tue, 11/7/17 - 09:56 am
ASH
Bluebird Bio
LentiGlobin
Ziopharm Oncology
Bellicum
BPX-501
Spark Therapeutics
SPK-8011
Biomarin
BMN 270
Juno Therapeutics
CAR-T
Novartis
Geron
imetelstat
Immunogen
IMGN632
IMGN779
Bluebird’s tweaked sickle cell gene therapy clears early test
Fierce Biotech
Wed, 11/1/17 - 06:42 pm
Bluebird Bio
sickle cell disease
gene therapy
HGB-206
Bluebird’s gene therapy halts progression of ‘devastating’ disease cALD
Fierce Biotech
Fri, 10/6/17 - 09:48 am
gene therapy
Bluebird Bio
cALD
Lenti-D
The new Biotech Scorecard: 10 make-or-break industry events for the fourth quarter
Stat
Tue, 10/3/17 - 11:50 am
biotech
Axovant Sciences
intepirdine
SAGE Therapeutics
brexanolone
AbbVie
risankizumab
Global Blood Therapeutics
GBT-440
DBV Technologies
Viaskin Peanut
Cytokinetics
Amicus Therapeutics
ATB200
Spark Therapeutics
Bluebird Bio
Revance Therapeutics
RT002
Why bluebird bio Inc Continued Its March Higher Again Today
Motley Fool
Thu, 08/31/17 - 10:13 pm
Bluebird Bio
bb2121
CAR-T
Novartis
Kymriah
Gilead Sciences
Kite Pharma
Why bluebird bio Inc and Juno Therapeutics Inc Shot Higher Today
Motley Fool
Mon, 08/28/17 - 10:26 pm
Bluebird Bio
Juno Therapeutics
Gilead Sciences
Kite Pharma
CAR-T
M&A
Pages
« first
‹ previous
…
6
7
8
9
10
11
12
13
14
next ›
last »